It’s a big pivot for organizations that traditionally create high-visibility fall projects to call attention to volunteerism and community service. In the process, they help dozens of neighborhood groups and scores of not-for-profits, from the United Way of Central Indiana to Keep Indianapolis Beautiful.
Hospital systems say their aim is to provide a helpful clearinghouse for patients in need of housing, transportation, food and other critical services—factors sometimes called “social determinants of health.”
The medical school said it is testing the use of tezampanel, an experimental drug for migraines developed by Indianapolis-based drugmaker Eli Lilly and Co., to treat opioid withdrawal syndrome and other addictions and mental illnesses.
A new study released Friday by the Rand Corp. found that Hoosiers covered by employer health plans paid Indiana hospitals three times what Medicare would have paid for the same procedures, exceeding the national rate of disparity.
The state’s Community Crossings grant program has awarded more than $730 million to projects in all 92 counties over the past four years.
On average, a patient admitted to an Indiana hospital with COVID-19 can look forward to staying for two weeks. That’s longer that the typical length of stay for pneumonia, a kidney transplant or open-heart surgery.
Just 12 years after opening to great fanfare, the future of the $150 million center, a partnership between the Indiana University School of Medicine and Indiana University Health, is full of questions.
The medical school said it will enroll up to 1,500 volunteers in a late-stage clinical trial for a vaccine being developed by British drugmaker AstraZeneca in partnership with Oxford University.
The Indianapolis-based utility said it also will spend $5 million to mitigate what critics say has been harm to the environment caused by the plant’s excess emissions over the years.
Lilly and partner Boehringer Ingelheim published results from a trial showing the drug cut the risk of cardiovascular hospitalizations or death by 25%, compared to placebo in heart failure patients.
Starting Monday, the state began including positive results from antigen tests along with its traditional PCR tests. That single move reduced the state’s testing-positivity rate—but some officials say the accuracy of antigen testing is still widely unknown.
The sudden departure follows accusations that Matthew Gutwein, 57, exploited legal loopholes to shift millions of dollars from nursing homes to the system’s Eskenazi Hospital and other programs.
Many health insurers are reporting second-quarter earnings double what they were a year ago, as Americans are putting off expensive surgeries and even routine office visits during the pandemic.
James Mladucky oversees some of the biggest building projects in Indiana. As vice president of design and construction at Indiana University Health, he is supervising the building of replacement hospitals in Bloomington and Frankfort, a hospital expansion in Avon and the recent construction of a cancer center in Carmel. Earlier this month, IU Health announced […]
The number of applications is more than triple what the state expected last month when it rolled out the program, which provides up to $500 in assistance a week for up to four weeks.
Advanced Penetration Technology LLC said London-based research laboratory Virology Research Services evaluated the anti-viral impact of the product and concluded it is a “highly effective formulation” against the coronavirus.
The Indianapolis-based startup is developing drugs targeting brain and bowel disorders.